Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
British Journal of Haematology|March 8, 2008
Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritisEva Baecklund, Yasodha Natkunam, Carin Backlin, et al.
Therapeutic Advances in Musculoskeletal Disease|November 9, 2023
Rheumatoid arthritis disease activity and adverse events in patients receiving tofacitinib or tumor necrosis factor inhibitors: a <i>post hoc</i> analysis of ORAL SurveillanceGeorge A Karpouzas, Zoltán Szekanecz, Eva Baecklund, et al.
Lupus Science & Medicine|June 18, 2019
Cell of origin in diffuse large B-cell lymphoma in systemic lupus erythematosus: molecular and clinical factors associated with survivalBasile Tessier-Cloutier, David Dw Twa, Eva Baecklund, et al.
Arthritis and Rheumatism|June 30, 2005
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in SwedenJohan Askling, C Michael Fored, Lena Brandt, et al.
RMD Open|December 23, 2022
Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort studyRene Lindholm Cordtz, Johan Askling, Benedicte Delcoigne, et al.
RMD Open|December 9, 2021
Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provisionHannah Bower, Thomas Frisell, Daniela di Giuseppe, et al.
Arthritis and Rheumatism|October 31, 2009
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: does the risk change with the time since start of treatment?Johan Askling, Ronald F van Vollenhoven, Fredrik Granath, et al.
Annals of the Rheumatic Diseases|February 24, 2021
Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort studyHannah Bower, Thomas Frisell, Daniela Di Giuseppe, et al.
Annals of the Rheumatic Diseases|January 31, 2007
Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonistsJohan Askling, C Michael Fored, Lena Brandt, et al.
Rheumatology (Oxford, England)|November 19, 2010
Ten years with biologics: to whom do data on effectiveness and safety apply?Julia F Simard, Elizabeth V Arkema, Anders Sundström, et al.
Pageof 7